An overview of optical coherence tomography for ovarian tissue imaging and characterization

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 7, Issue 1, 2015, Pages 1-16

  Wang, Tianheng ^a   Brewer, Molly ^b   Zhu, Quing ^a,c  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c University of Connecticut   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; OPTICAL PROPERTIES; OPTICAL TOMOGRAPHY;

BIOLOGICAL TISSUES; GYNECOLOGIC CANCER; HIGH RESOLUTION IMAGE; IMAGING MODALITY; OVARIAN CANCERS; OVARIAN TISSUE; QUANTITATIVE EXTRACTION; SCREENING TECHNIQUES;

TISSUE;

ARTICLE; B SCAN; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ECHOGRAPHY; FOURIER DOMAIN OPTICAL COHERENCE TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; LASER INDUCED FLUORESCENCE SPECTROSCOPY; MULTIMODAL IMAGING; MULTIPHOTON MICROSCOPY; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY DEVICE; OVARY; OVARY CANCER; OVARY CARCINOMA; PHOTOACOUSTICS; POLARIZATION SENSITIVE OPTICAL COHERENCE TOMOGRAPHY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; SPECTROSCOPY; SWEPT SOURCE OPTICAL COHERENCE TOMOGRAPHY; TRANSVAGINAL ECHOGRAPHY; TUMOR BIOPSY; ULTRASOUND TRANSDUCER; ACOUSTICS; CHEMISTRY; DIAGNOSTIC IMAGING; FEMALE; IMAGE PROCESSING; MICROSCOPY; OVARY TUMOR; PATHOLOGY; PROCEDURES;

CONTRAST MEDIUM;

ACOUSTICS; CONTRAST MEDIA; DIAGNOSTIC IMAGING; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MICROSCOPY; MULTIMODAL IMAGING; OVARIAN NEOPLASMS; OVARY; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84916640274     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.1306     Document Type: Article

References (94)

1. Fujimoto JG. Optical coherence tomography for ultrahigh resolution in vivo imaging. Nat Biotechnol 2003, 21:1361-1367.
2. Fercher AF, Drexler W, Hitzenberger CK, Lasser T. Optical coherence tomography-principles and applications. Rep Prog Phys 2003, 66:239-303.
3. Tomlins PH, Wang RK. Theory, developments and applications of optical coherence tomography. J Phys D Appl Phys 2005, 38:2519-2535.
4. Drexler W, Fujimoto JG. Optical Coherence Tomography: Technology and Applications. Berlin, Heidelberg: Springer; 2008.
5. Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, Hee MR, Flotte T, Gregory K, Puliafito CA, et al. Optical coherence tomography. Science 1991, 254:1178-1181.
6. Hee MR, Huang D, Swanson EA, Fujimoto JG. Polarization-sensitive low-coherence reflectometer for birefringence characterization and ranging. J Opt Soc Am B 1992, 9:903-908.
7. de Boer JF, Milner TE. Review of polarization sensitive optical coherence tomography and Stokes vector determination. J Biomed Opt 2002, 7:359-371.
8. Chen Z, Zhao Y, Srinivas SM, Nelson JS, Prakash N, Frostig RD. Optical Doppler tomography. IEEE J Sel Top Quantum Electron 1999, 5:1134-1142.
9. Rollins AM, Yazdanfar S, Barton JK, Izatt JA. Real-time in vivo color Doppler optical coherence tomography. J Biomed Opt 2002, 7:123-129.
10. Piao D, Otis L, Zhu Q. Doppler angle and flow velocity mapping by combining Doppler shift and Doppler bandwidth measurements in optical Doppler tomography. Opt Lett 2003, 28:1120-1123.
11. Leitgeb R, Schmetterer L, Drexler W, Fercher A, Zawadzki R, Bajraszewski T. Real-time assessment of retinal blood flow with ultrafast acquisition by color Doppler Fourier domain optical coherence tomography. Opt Express 2003, 11:3116-3121.
12. Schmitt JM, Xiang SH, Yung KM. Differential absorption imaging with optical coherence tomography. J Opt Soc Am A 1998, 15:2288-2296.
13. Morgner U, Drexler W, Kärtner FX, Li XD, Pitris C, Ippen EP, Fujimoto JG. Spectroscopic optical coherence tomography. Opt Lett 2000, 25:111-113.
14. Xu C, Carney P, Boppart S. Wavelength-dependent scattering in spectroscopic optical coherence tomography. Opt Express 2005, 13:5450-5462.
15. Fujimoto JG, Pitris C, Boppart SA, Brezinski ME. Optical coherence tomography: an emerging technology for biomedical imaging and optical biopsy. Neoplasia 2000, 2:9-25.
16. Vakoc BJ, Fukumura D, Jain RK, Bouma BE. Cancer imaging by optical coherence tomography: preclinical progress and clinical potential. Nat Rev Cancer 2012, 12:363-368.
17. Karanasos A, Ligthart J, Witberg K, van Soest G, Bruining N, Regar E. Optical coherence tomography: potential clinical applications. Curr Cardiovasc Imaging Rep 2012, 5:206-220.
18. Jaffe GJ, Caprioli J. Optical coherence tomography to detect and manage retinal disease and glaucoma. Am J Ophthalmol 2004, 137:156-169.
19. Yu L, Chen Z. Doppler variance imaging for three-dimensional retina and choroid angiography. J Biomed Opt 2010, 15:016029.
20. Li P, An L, Lan G, Johnstone M, Malchow D, Wang RK. Extended imaging depth to 12mm for 1050-nm spectral domain OCT for imaging whole anterior segment of human eye at 120kHz A-scan rate. J Biomed Opt 2013, 18:016012.
21. Otis LL, Everett MJ, Sathyam US, Colston BW Jr. Optical coherence tomography: a new imaging technology for dentistry. J Am Dent Assoc 2000, 131:511-514.
22. Holtzman JS, Osann K, Pharar J, Lee K, Ahn YC, Tucker T, Sabet S, Chen Z, Gukasyan R, Wilder-Smith P. Ability of optical coherence tomography to detect caries beneath commonly used dental sealants. Lasers Surg Med 2010, 42:752-759.
23. Chen YL, Yang Y, Ma J, Yan J, Shou Y, Wang T, Ramesh A, Zhao J, Zhu Q. 3D imaging of dental hard tissues with Fourier domain optical coherence tomography. Proc SPIE 2011, 7883:78834O.
24. Testoni PA, Mangiavillano B. Optical coherence tomography in detection of dysplasia and cancer of the gastrointestinal tract and bilio-pancreatic ductal system. World J Gastroenterol 2008, 14:6444-6452.
25. Cobb MJ, Hwang JH, Upton MP, Chen YC, Oelschlager BK, Wood DE, Kimmey MB, Li X. Imaging of subsquamous Barrett's epithelium with ultrahigh-resolution optical coherence tomography: a histologic correlation study. Gastrointest Endosc 2010, 71:223-230.
26. Tearney GJ, Yabushita H, Houser SL, Aretz HT, Jang IK, Schlendorf KH, Kauffman CR, Shishkov M, Halpern EF, Bouma BE. Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography. Circulation 2003, 107:113-119.
27. Barlis P, Serruys PW, Gonzalo N, van der Giessen WJ, de Jaegere PJ, Regar E. Assessment of culprit and remote coronary narrowings using optical coherence tomography with long-term outcomes. Am J Cardiol 2008, 102:391-395.
28. Bezerra HG, Costa MA, Guagliumi G, Rollins AM, Simon DI. Intracoronary optical coherence tomography: a comprehensive review clinical and research applications. JACC Cardiovasc Interv 2009, 2:1035-1046.
29. Shen B, Zuccaro G Jr, Gramlich TL, Gladkova N, Trolli P, Kareta M, Delaney CP, Connor JT, Lashner BA, Bevins CL, et al. In vivo colonoscopic optical coherence tomography for transmural inflammation in inflammatory bowel disease. Clin Gastroenterol Hepatol 2004, 2:1080-1087.
30. Boppart SA, Luo W, Marks DL, Singletary KW. Optical coherence tomography: feasibility for basic research and image-guided surgery of breast cancer. Breast Cancer Res Treat 2004, 84:85-97.
31. Mujat M, Ferguson RD, Hammer DX, Gittins C, Iftimia N. Automated algorithm for breast tissue differentiation in optical coherence tomography. J Biomed Opt 2009, 14:034040.
32. Curatolo A, McLaughlin RA, Quirk BC, Kirk RW, Bourke AG, Wood BA, Robbins PD, Saunders CM, Sampson DD. Ultrasound-guided optical coherence tomography needle probe for the assessment of breast cancer tumor margins. AJR Am J Roentgenol 2012, 199:W520-W522.
33. Cancer Facts and Figures 2014. Atlanta, GA, American Cancer Society. 2014.
34. Tammela J, Lele S. New modalities in detection of recurrent ovarian cancer. Curr Opin Obstet Gynecol 2004, 16:5-9.
35. Nossov V, Amneus M, Su F, Liang J, Janco JM, Reddy ST, Farias-Eisner R. The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125. Am J Obstet Gynecol 2008, 199:215-223.
36. Van Calster B, Timmerman D, Bourne T, Testa AC, Van Holsbeke C, Domali E, Jurkovic D, Neven P, Van Huffel S, Valentin L. Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125. J Natl Cancer Inst 2007, 99:1706-1714.
37. Goozner M. Personalizing ovarian cancer screening. J Natl Cancer Inst 2010, 102:1112-1113.
38. Shaaban A, Rezvani M. Ovarian cancer: detection and radiologic staging. Clin Obstet Gynecol 2009, 52:73-93.
39. Kauff ND, Satagopan JM, Robson ME, Scheuer L, Hensley M, Hudis CA, Ellis NA, Boyd J, Borgen PI, Barakat RR, et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 2002, 346:1609-1615.
40. Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, van't Veer L, Garber JE, Evans G, Isaacs C, Daly MB, Matloff E, et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 2002, 346:1616-1622.
41. Rocca WA, Grossardt BR, de Andrade M, Malkasian GD, Melton LJ. Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol 2006, 7:821-828.
42. Berek JS, Chalas E, Edelson M, Moore DH, Burke WM, Cliby WA, Berchuck A. Prophylactic and risk-reducing bilateral salpingo-oophorectomy: recommendations based on risk of ovarian cancer. Obstet Gynecol 2010, 116:733-743.
43. Brewer MA, Utzinger U, Barton JK, Hoying JB, Kirkpatrick ND, Brands WR, Davis JR, Hunt K, Stevens SJ, Gmitro AF. Imaging of the ovary. Technol Cancer Res Treat 2004, 3:617-627.
44. Leitgeb R, Hitzenberger CK, Fercher AF. Performance of fourier domain vs. time domain optical coherence tomography. Opt Express 2003, 11:889-894.
45. Choma M, Sarunic M, Yang C, Izatt J. Sensitivity advantage of swept source and Fourier domain optical coherence tomography. Opt Express 2003, 11:2183-2189.
46. Yang Y, Biswal N, Wang T, Kumavor P, Karimeddini M, Vento J, Sanders M, Brewer M, Zhu Q. Potential role of a hybrid intraoperative probe based on OCT and positron detection for ovarian cancer detection and characterization. Biomed Opt Express 2011, 2:1918-1930.
47. Yang Y, Wang T, Biswal NC, Wang X, Sanders M, Brewer M, Zhu Q. Optical scattering coefficient estimated by optical coherence tomography correlates with collagen content in ovarian tissue. J Biomed Opt 2011, 16:090504.
48. Yang Y, Wang T, Brewer M, Zhu Q. Quantitative analysis of angle-resolved scattering properties of ovarian tissue using optical coherence tomography. J Biomed Opt 2012, 17:090503.
49. Gamelin J, Yang Y, Biswal N, Chen Y, Yan S, Zhang X, Karemeddini M, Brewer M, Zhu Q. A prototype hybrid intraoperative probe for ovarian cancer detection. Opt Express 2009, 17:7245-7258.
50. Yang Y, Li X, Wang T, Kumavor P, Aguirre A, Shung K, Zhou Q, Sanders M, Brewer M, Zhu Q. Integrated optical coherence tomography, ultrasound and photoacoustic imaging for ovarian tissue characterization. Biomed Opt Express 2011, 2:2551-2561.
51. Kanter EM, Walker RM, Marion SL, Brewer M, Hoyer PB, Barton JK. Dual modality imaging of a novel rat model of ovarian carcinogenesis. J Biomed Opt 2006, 11:041123.
52. Hariri LP, Liebmann ER, Marion SL, Hoyer PB, Davis JR, Brewer MA, Barton JK. Simultaneous optical coherence tomography and laser induced fluorescence imaging in rat model of ovarian carcinogenesis. Cancer Biol Ther 2010, 10:438-447.
53. Watson JM, Marion SL, Rice PF, Bentley DL, Besselsen DG, Utzinger U, Hoyer PB, Barton JK. In vivo time-serial multi-modality optical imaging in a mouse model of ovarian tumorigenesis. Cancer Biol Ther 2014, 15:42-60.
54. Boppart SA, Goodman A, Libus J, Pitris C, Jesser CA, Brezinski ME, Fujimoto JG. High resolution imaging of endometriosis and ovarian carcinoma with optical coherence tomography: feasibility for laparoscopic-based imaging. Brit J Obstet Gynaec 1999, 106:1071-1077.
55. Hariri LP, Bonnema GT, Schmidt K, Winkler AM, Korde V, Hatch KD, Davis JR, Brewer MA, Barton JK. Laparoscopic optical coherence tomography imaging of human ovarian cancer. Gynecol Oncol 2009, 114:188-194.
56. Evans CL, Rizvi I, Hasan T, de Boer JF. In vitro ovarian tumor growth and treatment response dynamics visualized with time-lapse OCT imaging. Opt Express 2009, 17:8892-8906.
57. Fine JL, Kagemann L, Wollstein G, Ishikawa H, Schuman JS. Direct scanning of pathology specimens using spectral domain optical coherence tomography: a pilot study. Ophthalmic Surg Lasers Imaging 2010, 41:S58-S64.
58. Korde VR, Liebmann E, Barton JK. Design of a handheld optical coherence microscopy endoscope. J Biomed Opt 2011, 16:066018.
59. Arifler D, Pavlova I, Gillenwater A, Richards-Kortum R. Light scattering from collagen fiber networks: micro-optical properties of normal and neoplastic stroma. Biophys J 2007, 92:3260-3274.
60. Faber D, van der Meer F, Aalders M, van Leeuwen T. Quantitative measurement of attenuation coefficients of weakly scattering media using optical coherence tomography. Opt Express 2004, 12:4353-4365.
61. Lee P, Gao W, Zhang X. Performance of single-scattering model versus multiple-scattering model in the determination of optical properties of biological tissue with optical coherence tomography. Appl Opt 2010, 49:3538-3544.
62. de Boer JF, Milner TE, van Gemert MJC, Nelson JS. Two-dimensional birefringence imaging in biological tissue by polarization-sensitive optical coherence tomography. Opt Lett 1997, 22:934-936.
63. Cense B, Chen TC, Park BH, Pierce MC, de Boer JF. Thickness and birefringence of healthy retinal nerve fiber layer tissue measured with polarization-sensitive optical coherence tomography. Invest Ophthalmol Vis Sci 2004, 45:2606-2612.
64. Elmaanaoui B, Wang B, Dwelle JC, McElroy AB, Liu SS, Rylander HG, Milner TE. Birefringence measurement of the retinal nerve fiber layer by swept source polarization sensitive optical coherence tomography. Opt Express 2011, 19:10252-10268.
65. Zotter S, Pircher M, Götzinger E, Torzicky T, Yoshida H, Hirose F, Holzer S, Kroisamer J, Vass C, Schmidt-Erfurth U, et al. Measuring retinal nerve fiber layer birefringence, retardation, and thickness using wide-field, high-speed polarization sensitive spectral domain OCT. Invest Ophthalmol Vis Sci 2013, 54:72-84.
66. Fried D, Xie J, Shafi S, Featherstone JDB, Breunig TM, Le C. Imaging caries lesions and lesion progression with polarization sensitive optical coherence tomography. J Biomed Opt 2002, 7:618-627.
67. Chen Y, Otis L, Piao D, Zhu Q. Characterization of dentin, enamel, and carious lesions by a polarization-sensitive optical coherence tomography system. Appl Opt 2005, 44:2041-2048.
68. Nadkarni SK, Pierce MC, Park BH, de Boer JF, Whittaker P, Bouma BE, Bressner JE, Halpern E, Houser SL, Tearney GJ. Measurement of collagen and smooth muscle cell content in atherosclerotic plaques using polarization-sensitive optical coherence tomography. J Am Coll Cardiol 2007, 49:1474-1481.
69. Kuo W, Chou N, Chou C, Lai C, Huang H, Wang S, Shyu J. Polarization-sensitive optical coherence tomography for imaging human atherosclerosis. Appl Opt 2007, 46:2520-2527.
70. Strasswimmer J, Pierce MC, Park BH, Neel V, de Boer JF. Polarization-sensitive optical coherence tomography of invasive basal cell carcinoma. J Biomed Opt 2004, 9:292-298.
71. Sakai S, Yamanari M, Miyazawa A, Matsumoto M, Nakagawa N, Sugawara T, Kawabata K, Yatagai T, Yasuno Y. In vivo three-dimensional birefringence analysis shows collagen differences between young and old photo-aged human skin. J Invest Dermatol 2008, 128:1641-1647.
72. Sakai S, Yamanari M, Lim Y, Nakagawa N, Yasuno Y. In vivo evaluation of human skin anisotropy by polarization-sensitive optical coherence tomography. Biomed Opt Express 2011, 2:2623-2631.
73. Yang Y, Wang T, Wang X, Sanders M, Brewer M, Zhu Q. Quantitative analysis of estimated scattering coefficient and phase retardation for ovarian tissue characterization. Biomed Opt Express 2012, 3:1548-1556.
74. Wang T, Yang Y, Zhu Q. A three-parameter logistic model to characterize ovarian tissue using polarization-sensitive optical coherence tomography. Biomed Opt Express 2013, 4:772-777.
75. Piert M, Burian M, Meisetschläger G, Stein HJ, Ziegler S, Nährig J, Picchio M, Buck A, Siewert JR, Schwaiger M. Positron detection for the intraoperative localisation of cancer deposits. Eur J Nucl Med Mol Imaging 2007, 34:1534-1544.
76. Bogalhas F, Charon Y, Duval MA, Lefebvre F, Palfi S, Pinot L, Siebert R, Ménard L. Development of a positron probe for localization and excision of brain tumours during surgery. Phys Med Biol 2009, 54:4439-4453.
77. Piao D, Sadeghi MM, Zhang J, Chen Y, Sinusas AJ, Zhu Q. Hybrid positron detection and optical coherence tomography system: design, calibration, and experimental validation with rabbit atherosclerotic models. J Biomed Opt 2005, 10:044010.
78. Xu M, Wang LV. Photoacoustic imaging in biomedicine. Rev Sci Instrum 2006, 77:041101.
79. Wang LV, Hu S. Photoacoustic tomography: in vivo imaging from organelles to organs. Science 2012, 335:1458-1462.
80. Aguirre A, Ardeshirpour Y, Sanders MM, Brewer M, Zhu Q. Potential role of coregistered photoacoustic and ultrasound imaging in ovarian cancer detection and characterization. Transl Oncol 2011, 4:29-37.
81. Alqasemi U, Kumavor P, Aguirre A, Zhu Q. Recognition algorithm for assisting ovarian cancer diagnosis from coregistered ultrasound and photoacoustic images: ex vivo study. J Biomed Opt 2012, 17:126003.
82. Kumavor PD, Alqasemi U, Tavakoli B, Li H, Yang Y, Sun X, Warych E, Zhu Q. Co-registered pulse-echo/photoacoustic transvaginal probe for real time imaging of ovarian tissue. J Biophotonics 2013, 6:475-484.
83. Ramanujam N. Fluorescence spectroscopy of neoplastic and non-neoplastic tissues. Neoplasia 2000, 2:89-117.
84. Williams RM, Flesken-Nikitin A, Ellenson LH, Connolly DC, Hamilton TC, Nikitin AY, Zipfel WR. Strategies for high-resolution imaging of epithelial ovarian cancer by laparoscopic nonlinear microscopy. Transl Oncol 2010, 3:181-194.
85. Yao J, Wang LV. Photoacoustic microscopy. Laser Photon Rev 2013, 7:758-778.
86. Wang T, Yang Y, Alqasemi U, Kumavor P, Wang X, Sanders M, Brewer M, Zhu Q. Characterization of ovarian tissue based on quantitative analysis of photoacoustic microscopy images. Biomed Opt Express 2013, 4:2763-2768.
87. Li L, Maslov K, Ku G, Wang LV. Three-dimensional combined photoacoustic and optical coherence microscopy for in vivo microcirculation studies. Opt Express 2009, 17:16450-16455.
88. Zhang X, Zhang H, Jiao S. Optical coherence photoacoustic microscopy: accomplishing optical coherence tomography and photoacoustic microscopy with a single light source. J Biomed Opt 2012, 17:030502.
89. Boccara C, Harms F, Latrive A. Full-field OCT: a non-invasive tool for diagnosis and tissue selection. SPIE Newsroom 2013, 1-4. doi: 10.1117/2.1201306.004933.
90. Cragun JM. Screening for ovarian cancer. Cancer Control 2011, 18:16-21.
91. Parker WH, Broder MS, Liu Z, Shoupe D, Farquhar C, Berek JS. Ovarian conservation at the time of hysterectomy for benign disease. Obstet Gynecol 2005, 106:219-226.
92. Parker WH, Broder MS, Liu Z, Shoupe D, Farquhar C, Berek JS. Ovarian conservation at the time of hysterectomy for benign disease. Clin Obstet Gynecol 2007, 50:354-361.
93. Shoupe D, Parker WH, Broder MS, Liu Z, Farquhar C, Berek JS. Elective oophorectomy for benign gynecological disorders. Menopause 2007, 14:580-585.
94. Parker WH, Broder MS, Chang E, Feskanich D, Farquhar C, Liu Z, Shoupe D, Berek JS, Hankinson S, Manson JE. Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study. Obstet Gynecol 2009, 113:1027-1037.